Mr. Ubben quit ValueAct Capital to focus on his social investment profession. Following his departure from his position as a research analyst at Credit Suisse, Mason Morfit joined the company in 2001. He is the activist hedge fund’s CEO and CIO at the moment. He has been on Microsoft’s board of directors for more than 20 years. ValueAct’s original long-term investment ideas will remain in place and won’t be altered, according to Mr. Morfit. The distinctive way that ValueAct Capital approaches activist investing is well known. ValueAct prefers to collaborate with board members over overturning the board of a corporation. The aim of the hedge fund is to increase shareholder returns and depart from a firm in a stronger position than when they first went long. A 4.4 percent stake in Seven & I Holdings Co. Ltd. is held by ValueAct Capital. Earlier this year, the company’s board of directors received a letter from the activist hedge fund. On important strategic concerns, ValueAct is asking for direct and open shareholder input. Through 2019, ValueAct Capital has reported a median annualized return of around 14%. The fund’s gains decreased from a negative 5.18 percent quarter-on-quarter in Q4 2021 to a negative 19.61 percent in the first quarter of 2022. ValueAct Capital has maintained its top 10 holdings for one-third of 14 quarters, or nearly three and a half years, and has a top 10 holdings concentration of 99.55 percent. In the first quarter of 2022, ValueAct Capital increased its stakes in two of its previously held positions while going long in one new firm.
Insider Monkey highlights the 10 best stocks to buy for the long term according to ValueAct Capital. The $38.88 million value of ValueAct Capital’s holding in TopBuild Corp. represents 0.53 percent of its 13F portfolio. For the construction industry, the business installs and distributes insulation as well as other building materials. Private education loans are originated and serviced by SLM Corporation. SLM Corporation shares worth 13.9 million are owned by ValueAct Capital. With a forward dividend yield of 2.66 percent and a trailing-twelve-month PE ratio of 6.75, the company is profitable. The third-largest shareholder in Bausch Health Companies is ValueAct Capital. More than 14.43 million shares of the healthcare company are owned by the activist hedge fund. 4.53 percent of ValueAct Capital’s investment portfolio is represented by the investment. Hardware, software, and services for information technology are offered by Insight Enterprises, Inc. Cloud enablement services, data & AI, DevOps, digital strategy, intelligent apps & edge, and IoT solutions are among the company’s product offerings. With a trailing 12-month PE ratio of 5.46 and a 4.35 percent dividend yield, Citigroup Inc. is a good investment. More than 13.84 million shares, or $739.38 million, of the bank holding company are owned by ValueAct Capital. For more details, click 10 Best Stocks To Buy For The Long Term According To ValueAct Capital.
